Herb Greenberg  |  On the Street

Herb Greenberg | On the Street

Share this post

Herb Greenberg  |  On the Street
Herb Greenberg | On the Street
Red Flag Alert – Hims Hits the Radar
Copy link
Facebook
Email
Notes
More
Red Flag Alerts

Red Flag Alert – Hims Hits the Radar

Herb Greenberg's avatar
Herb Greenberg
May 28, 2024
∙ Paid
10

Share this post

Herb Greenberg  |  On the Street
Herb Greenberg | On the Street
Red Flag Alert – Hims Hits the Radar
Copy link
Facebook
Email
Notes
More
Share
Source: Hims press release announcing its GLP-1

(This friendly reminder: My Red Flag Alerts and selected On the Street content is no longer free. But while the paint is still drying on my paywall, my introductory price remains the same. For more info, here’s more about my decision to go paid, and what to expect from my Red Flag Alerts.)


I’m adding Hims & Hers Health ($HIMS) to my Red Flag Alerts...

The stock leaped to life last week after the telehealth platform known best for its erectile dysfunction and hair loss products announced it was adding a compounded GLP-1 weight-loss drug to its lineup.

The bull story is focused on strong margins and subscriber growth...

Beyond that, the model appears to be challenged, which is why I’m adding it to Red Flag Alerts.

In going over it with my friend Russell Young of Decameron Capital, who recently shorted the stock and is hoping to add more, here are some of the reasons, in no particular order...

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Herb Greenberg
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More